These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 21824086)
21. Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Mori TA; Bao DQ; Burke V; Puddey IB; Beilin LJ Hypertension; 1999 Aug; 34(2):253-60. PubMed ID: 10454450 [TBL] [Abstract][Full Text] [Related]
22. Docosahexaenoic acid and eicosapentaenoic acid affect ovarian prostaglandin levels differently in rats. Broughton KS; Hahn B; Ross E Nutr Res; 2009 Jul; 29(7):510-8. PubMed ID: 19700039 [TBL] [Abstract][Full Text] [Related]
23. Eicosapentaenoic acid and docosahexaenoic acid from fish oils: differential associations with lipid responses. Leigh-Firbank EC; Minihane AM; Leake DS; Wright JW; Murphy MC; Griffin BA; Williams CM Br J Nutr; 2002 May; 87(5):435-45. PubMed ID: 12010583 [TBL] [Abstract][Full Text] [Related]
24. Effect of dietary supplementation with long-chain n-3 fatty acids during late gestation and early lactation on mare and foal plasma fatty acid composition, milk fatty acid composition, and mare reproductive variables. Kouba JM; Burns TA; Webel SK Anim Reprod Sci; 2019 Apr; 203():33-44. PubMed ID: 30803694 [TBL] [Abstract][Full Text] [Related]
25. Lipid remodeling and an altered membrane-associated proteome may drive the differential effects of EPA and DHA treatment on skeletal muscle glucose uptake and protein accretion. Jeromson S; Mackenzie I; Doherty MK; Whitfield PD; Bell G; Dick J; Shaw A; Rao FV; Ashcroft SP; Philp A; Galloway SDR; Gallagher I; Hamilton DL Am J Physiol Endocrinol Metab; 2018 Jun; 314(6):E605-E619. PubMed ID: 28655718 [TBL] [Abstract][Full Text] [Related]
26. In vitro effect of eicosapentaenoic and docosahexaenoic acids on prostaglandin E2 synthesis in a human lung carcinoma. de Antueno RJ; de Bravo MG; Toledo J; Mercuri O; De Tomás ME Biochem Int; 1989 Sep; 19(3):489-96. PubMed ID: 2554913 [TBL] [Abstract][Full Text] [Related]
27. The differential effects of EPA and DHA on cardiovascular risk factors. Cottin SC; Sanders TA; Hall WL Proc Nutr Soc; 2011 May; 70(2):215-31. PubMed ID: 21349231 [TBL] [Abstract][Full Text] [Related]
28. Circulating CD36+ microparticles are not altered by docosahexaenoic or eicosapentaenoic acid supplementation. Phang M; Thorne RF; Alkhatatbeh MJ; Garg ML; Lincz LF Nutr Metab Cardiovasc Dis; 2016 Mar; 26(3):254-60. PubMed ID: 26803595 [TBL] [Abstract][Full Text] [Related]
29. Divergent effects of eicosapentaenoic and docosahexaenoic acid ethyl esters, and fish oil on hepatic fatty acid oxidation in the rat. Hong DD; Takahashi Y; Kushiro M; Ide T Biochim Biophys Acta; 2003 Nov; 1635(1):29-36. PubMed ID: 14642774 [TBL] [Abstract][Full Text] [Related]
30. Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: a review. Jacobson TA; Glickstein SB; Rowe JD; Soni PN J Clin Lipidol; 2012; 6(1):5-18. PubMed ID: 22264569 [TBL] [Abstract][Full Text] [Related]
31. Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on fatty acid absorption, incorporation into serum phospholipids and postprandial triglyceridemia. Hansen JB; Grimsgaard S; Nilsen H; Nordøy A; Bønaa KH Lipids; 1998 Feb; 33(2):131-8. PubMed ID: 9507234 [TBL] [Abstract][Full Text] [Related]
33. Low levels of eicosapentaenoic and docosahexaenoic acids mimic the effects of fish oil upon rat lymphocytes. Peterson LD; Thies F; Sanderson P; Newsholme EA; Calder PC Life Sci; 1998; 62(24):2209-17. PubMed ID: 9627080 [TBL] [Abstract][Full Text] [Related]
34. EPA + DHA supplementation reduces PMN activation in microenvironment of chronic venous leg ulcers: A randomized, double-blind, controlled study. McDaniel JC; Szalacha L; Sales M; Roy S; Chafee S; Parinandi N Wound Repair Regen; 2017 Aug; 25(4):680-690. PubMed ID: 28758717 [TBL] [Abstract][Full Text] [Related]
36. EPA and DHA differentially affect in vitro inflammatory cytokine release by peripheral blood mononuclear cells from Alzheimer's patients. Serini S; Bizzarro A; Piccioni E; Fasano E; Rossi C; Lauria A; Cittadini AR; Masullo C; Calviello G Curr Alzheimer Res; 2012 Oct; 9(8):913-23. PubMed ID: 22299617 [TBL] [Abstract][Full Text] [Related]
37. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story. Singh S; Arora RR; Singh M; Khosla S Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517 [TBL] [Abstract][Full Text] [Related]
38. Eicosapentaenoic and docosahexaenoic acid affect mitochondrial and peroxisomal fatty acid oxidation in relation to substrate preference. Madsen L; Rustan AC; Vaagenes H; Berge K; Dyrøy E; Berge RK Lipids; 1999 Sep; 34(9):951-63. PubMed ID: 10574660 [TBL] [Abstract][Full Text] [Related]
39. Very long-chain n-3 fatty acids and human health: fact, fiction and the future. Calder PC Proc Nutr Soc; 2018 Feb; 77(1):52-72. PubMed ID: 29039280 [TBL] [Abstract][Full Text] [Related]
40. Long-term supplementation with eicosapentaenoic acid salvages cardiomyocytes from hypoxia/reoxygenation-induced injury in rats fed with fish-oil-deprived diet. Nasa Y; Hayashi M; Sasaki H; Hayashi J; Takeo S Jpn J Pharmacol; 1998 Jun; 77(2):137-46. PubMed ID: 9681570 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]